Results 201 to 210 of about 2,861,731 (308)

Criteria for Hidradenitis Suppurativa Competence Centers. [PDF]

open access: yesDermatol Ther (Heidelb)
Marzano AV   +23 more
europepmc   +1 more source

Ernst Brandenburg

open access: yes, 1963
Schmutterer, Heinz   +1 more
openaire   +3 more sources

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

open access: yesInternational Journal of Cancer, Volume 159, Issue 1, Page 210-223, 1 July 2026.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching   +20 more
wiley   +1 more source

Shaping expectations, losing flexibility: A study of CEO promises as strategic communication tools

open access: yesStrategic Management Journal, Volume 47, Issue 7, Page 1980-2061, July 2026.
Abstract Research Summary CEO promises are powerful but understudied communication tools. We develop a dual‐mechanism framework theorizing that while CEO promises elevate stakeholder expectations, they simultaneously constrain strategic flexibility. We argue that CEO promise‐making is shaped by two competing pressures: making more promises when the ...
Majid Majzoubi   +2 more
wiley   +1 more source

Beyond the headlines: the intangible costs of terrorism

open access: yesEconomica, Volume 93, Issue 371, Page 1122-1144, July 2026.
Abstract Do terrorist attacks affect life satisfaction and mental health? To explore this question, we analyse data on all casualty‐causing terrorist incidents in Great Britain from 1992 to 2020, and combine this information with individual‐level data from the British Household Panel Survey and the UK Household Longitudinal Study over the same period ...
Harry Pickard   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy